The association between circulating adiponectin levels, lung function and adiposity in subjects from the general population; data from the Akershus Sleep Apnea Project
Open Access
- 2 April 2018
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 18 (1) , 54
Abstract
Circulating adiponectin (ADPN) levels are inversely associated with disease severity in patients with chronic obstructive pulmonary disease (COPD), while studies assessing the relationship between ADPN and lung function in subjects from the general population have shown diverging results. Accordingly, we hypothesized that ADPN would be associated with lung function in a population-based sample and tested how abdominal adiposity, metabolic syndrome, and systemic inflammation influenced this association. We measured total ADPN in serum, forced vital capacity (FVC) and forced expiratory volume during the 1st second (FEV1) in 529 participants (median 50 years, 54.6% males) recruited from the general population. We assessed the association between ADPN and lung function by multivariate linear regression analyses and adjusted for age, gender, height, smoking habits, weight, body mass index, waist-hip ratio, metabolic syndrome, obstructive sleep apnoea (OSA) and C-reactive protein. The median (interquartile range) level of serum ADPN was 7.6 (5.4-10.4) mg/L. ADPN levels were positively associated with FVC % of predicted (beta 3.4 per SD adiponectin, p < 0.001)) in univariate linear regression analysis, but the association was attenuated in multivariate analysis (standardized beta 0.03, p = 0.573)). Among co-variates only WHR significantly attenuated the relationship. ADPN levels were also associated with FEV1% of predicted in bivariate analysis that adjusted for smoking (beta 1.4, p = 0.042)), but this association was attenuated and no longer significant in multivariate analysis (standardized beta -0.06, p = 0.254)). In this population-based sample no association between ADPN and lung function was evident after adjustment for covariates related to adiposity.Keywords
Funding Information
- Helse Sør-Øst RHF (2004219,2007048)
- Extrastiftelsen in collaboration with the Norwegian Heart and Lung Association (2015/F07781)
This publication has 24 references indexed in Scilit:
- Biomarkers in COPDClinics in Chest Medicine, 2014
- Relationship between serum adiponectin levels and age in healthy subjects and patients with type 2 diabetesClinical Endocrinology, 2012
- Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular diseaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- A Norwegian population-based study on the risk and prevalence of obstructive sleep apnea The Akershus Sleep Apnea Project (ASAP)Journal of Sleep Research, 2011
- Distribution of plasma levels of adiponectin and leptin in an adult Caucasian populationClinical Endocrinology, 2009
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Increased serum adiponectin levels in type 1 diabetic patients with microvascular complicationsDiabetologia, 2005
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityNature Medicine, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease StudyThe Lancet, 1997